Home » Topics » Regulatory » Patents

Patents
RSS

Bristol-Myers Squibb and Rigel Pharmaceuticals describe TGF-beta1 inhibitors

Sep. 20, 2016

Eli Lilly discloses GPR142 agonists

Sep. 20, 2016

Shanghai Institute Materia Medica patents anticancer agents

Sep. 20, 2016

Nitto Denko patents carboxylesterase inhibitors

Sep. 16, 2016

Bristol-Myers Squibb reports development of NS5B inhibitors

Sep. 13, 2016

Bayer Pharma describes anticancer agents

Sep. 13, 2016

Sunshine Lake Pharma and Calitor Sciences disclose PI3Kdelta inhibitors

Sep. 13, 2016

SK Biopharmaceuticals patents mGlu5 receptor PAMs

Sep. 13, 2016

Sage Therapeutics announces GABA(A) receptor modulators

Sep. 12, 2016

Incyte presents FGFR-4 inhibitors

Sep. 12, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...